Skinvisible granted Australian patent

The Invisicare patent provides protection in the areas of topical composition, topical composition precursor, and methods for manufacturing and using. This patent will assist Skinvisible’s sales efforts in Australia by protecting its Invisicare technology and formulated products.

According to the company, Invisicare has a unique ability to hold active ingredients on the skin for extended periods of time while resisting wash-off, rub-off and perspiration. This benefit leads to additional unique enhancements to topical dermatology products.

Additionally, Invisicare provides product life-cycle management by allowing for new patent protection for products coming off patent and providing improved claims to formulations of cosmetics, over-the-counter and prescription skincare products.

Terry Howlett, president and CEO of Skinvisible, said: “Having our Invisicare patent approved in Australia is one more degree of protection that we can provide to our international licensees. We continue to submit for patent protection worldwide for all products formulated with Invisicare.”